Developing treatments for patients is not new but developing treatments with patients is. Increasingly, new evidence-based guidelines outline ways in which patients need to play a central role in their own care in order to improve outcomes, moving patient-centricity from the sidelines to the front lines across R&D and disease management efforts.
In response, more life science companies are looking for ways to engage with and influence consumers directly, embracing a more patient-centric approach focused on delivering customized care solutions. Despite these efforts, only 9% of U.S. consumers believe pharma and biotechnology companies put patients over profits, according to a 2016 Harris Poll. That leaves a trust and credibility gap that life science organizations must address to build and strengthen consumer relationships. Life sciences firms still have a fundamental decision to make. Are they going to be treatment providers or life partners for their patients?
This webinar will present a framework to embed patient-centricity into the daily operations and cultural DNA of the organization in order to deliver the industry’s new mandate.